| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FNDC3B_0018200 | Intron-Exon-Intron | chr3:171969050-172037835 | chr3:172251260-172320045 | 199 nt | 0.4874 |
| hsa_FNDC3B_0018300 | Exon-Exon | chr3:171969050-172055191 | chr3:172251260-172337401 | 78 nt | 0.3846 |
| hsa_FNDC3B_0017900 | Exon-Exon | chr3:171969050-172065151 | chr3:172251260-172347361 | 2006 nt | 0.4880 |
| hsa_FNDC3B_0018400 | Exon-Exon | chr3:171969189-172028671 | chr3:172251399-172310881 | 54 nt | 0.4259 |
| hsa_FNDC3B_0018500 | Exon-Exon | chr3:171969261-172013304 | chr3:172251471-172295514 | 130 nt | 0.4462 |
| hsa_FNDC3B_0018600 | Intron-Intron | chr3:171969884-171970101 | chr3:172252094-172252311 | 218 nt | 0.3670 |
| hsa_FNDC3B_0018700 | Intron-Intron | chr3:171969943-171970105 | chr3:172252153-172252315 | 163 nt | 0.3620 |
| hsa_chr3_0367300 | Intergenic-Intergenic | chr3:171972498-171973061 | chr3:172254708-172255271 | 564 nt | 0.4078 |
| hsa_FNDC3B_0018800 | Intron-Intron | chr3:171974979-171996440 | chr3:172257189-172278650 | 250 nt | 0.3280 |
| hsa_FNDC3B_0018900 | Intron-Intron | chr3:171976850-171979873 | chr3:172259060-172262083 | 250 nt | 0.2760 |
A study in mice demonstrated that the circFNDC3B was significantly downregulated in hearts post-myocardial infarction and in human cardiac tissues of ischemic cardiomyopathy patients, where its overexpression in cardiac endothelial cells increased vascular endothelial growth factor expression, enhanced angiogenic activity, and reduced apoptosis [Tian et al. DOI:10.3390/molecules26041155].